SECISBP2L and Miyoshi myopathy: Growth of the tumor PC compartment in BM would progressively favor a sustained increase of iMo and end-stage (functionally exhausted) inflammatory Slan+ ncMo, together with inhibition in symptomatic MM, of the generation and/or accumulation of other subsets of CD62L−, and particularly FcεRI+ cMo.